AAM
MRTX

Alpine Associates Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Alpine Associates Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,881,400
Closed -$111M – 58
2023
Q4 		$111M Buy
+1,881,400
New +$111M 5.67% 5